These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 24611965)
1. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery. Raj A; Saraf P; Javali NM; Li X; Jasti B J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965 [TBL] [Abstract][Full Text] [Related]
2. Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors. Javali NM; Raj A; Saraf P; Li X; Jasti B Pharm Res; 2012 Dec; 29(12):3347-61. PubMed ID: 22825750 [TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel. Saraf P; Li X; Wrischnik L; Jasti B Pharm Res; 2015 Sep; 32(9):3087-101. PubMed ID: 26063045 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of RGD-fatty acid amphiphilic micelles as targeted delivery carriers for anticancer agents. Shen SI; Kotamraj PR; Bhattacharya S; Li X; Jasti BR J Drug Target; 2007 Jan; 15(1):51-8. PubMed ID: 17365273 [TBL] [Abstract][Full Text] [Related]
5. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117 [TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
7. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery. Hu Z; Luo F; Pan Y; Hou C; Ren L; Chen J; Wang J; Zhang Y J Biomed Mater Res A; 2008 Jun; 85(3):797-807. PubMed ID: 17896765 [TBL] [Abstract][Full Text] [Related]
8. Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel. Gao Y; Zhang C; Zhou Y; Li J; Zhao L; Li Y; Liu Y; Li X Pharm Res; 2015 Aug; 32(8):2649-62. PubMed ID: 25676595 [TBL] [Abstract][Full Text] [Related]
9. Effect of integrin targeting and PEG shielding on polyplex micelle internalization studied by live-cell imaging. Mickler FM; Vachutinsky Y; Oba M; Miyata K; Nishiyama N; Kataoka K; Bräuchle C; Ruthardt N J Control Release; 2011 Dec; 156(3):364-73. PubMed ID: 21843561 [TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054 [TBL] [Abstract][Full Text] [Related]
11. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering. Guo Z; He B; Jin H; Zhang H; Dai W; Zhang L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2014 Jul; 35(23):6106-17. PubMed ID: 24794924 [TBL] [Abstract][Full Text] [Related]
12. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide. Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655 [TBL] [Abstract][Full Text] [Related]
13. Dual-targeting liposomes with active recognition of GLUT Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3. Yu YP; Wang Q; Liu YC; Xie Y Biomaterials; 2014 Feb; 35(5):1667-75. PubMed ID: 24268666 [TBL] [Abstract][Full Text] [Related]
15. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312 [TBL] [Abstract][Full Text] [Related]
16. Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro. Wang Y; Yang T; Wang X; Wang J; Zhang X; Zhang Q Pharm Res; 2010 Sep; 27(9):1861-8. PubMed ID: 20559700 [TBL] [Abstract][Full Text] [Related]
17. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy. Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098 [TBL] [Abstract][Full Text] [Related]
18. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature. Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083 [TBL] [Abstract][Full Text] [Related]
19. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor. Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321 [TBL] [Abstract][Full Text] [Related]
20. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]